Status:
COMPLETED
Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion
Lead Sponsor:
Samsung Medical Center
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to establish the optimal strategy for side branch stenting in coronary bifurcation lesion.
Detailed Description
The purpose of this study is to evaluate the relative efficacy and safety of conservative strategy compared to aggressive strategy for side branch stenting in coronary bifurcation lesion.
Eligibility Criteria
Inclusion
- Parent vessel diameter stenosis \> 75%
- Parent vessel diameter stenosis 50% - 75% with angina and/or objective evidence of ischemia in the non-invasive stress test
- The reference diameter of both branches more than 2.3 mm by visual estimation
Exclusion
- Cardiogenic shock
- ST-elevation myocardial infarction within 48 hours of symptom onset
- Left ventricular dysfunction (echocardiographic left ventricular ejection fraction \< 25%)
- Graft vessels
- Patients who have to receive clopidogrel due to other conditions
- Patients who have to receive warfarin, cilostazol or other antiplatelet therapy
- Hypersensitivity to clopidogrel or aspirin
- Expectant survival less than 1 year
- Women who plan to become pregnant
- Patients with bleeding diathesis (coagulopathy, thrombocytopenia or platelet dysfunction, Gastrointestinal or genitourinary bleeding within the prior 3 months)
- Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
258 Patients enrolled
Trial Details
Trial ID
NCT00794014
Start Date
November 1 2007
End Date
February 1 2012
Last Update
February 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710